Evaluation of UGT protein interactions in human hepatocytes: Effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes

被引:10
作者
Konopnicki, Camille M. [1 ]
Dickmann, Leslie J. [2 ]
Tracy, Jeffrey M. [3 ]
Tukey, Robert H. [1 ]
Wienkers, Larry C. [2 ]
Foti, Robert S. [2 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Amgen Inc, Pharmacokinet & Drug Metab, Seattle, WA 98119 USA
[3] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA
关键词
UDP-Glucuronosyltransferase; siRNA; Protein interactions; Hepatocytes; HUMAN UDP-GLUCURONOSYLTRANSFERASES; HUMAN DRUG GLUCURONIDATION; IN-VITRO; METABOLIZING-ENZYMES; LIVER-MICROSOMES; CYTOCHROME-P450; MODULATION; EXPRESSION; HOMODIMERIZATION; INACTIVATION;
D O I
10.1016/j.abb.2013.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous experiments performed in recombinant systems have suggested that protein-protein interactions occur between the UGTs and may play a significant role in modulating enzyme activity. However, evidence of UGT protein protein interactions either in vivo or in more physiologically relevant in vitro systems has yet to be demonstrated. In this study, we examined oligomerization and its ability to affect glucuronidation in plated human hepatocytes. siRNA down regulation experiments and activity studies were used to examine changes in metabolite formation of one UGT isoform due to down regulation of a second UGT isoform. Selective siRNA directed towards UGT1A9 or UGT2B7 resulted in significant and selective decreases in their respective mRNA levels. As expected, the metabolism of the UGT1A9 substrate propofol decreased with UGT1A9 down regulation. Interestingly, UGT1A9 activity, but not UGT1A9 mRNA expression, was also diminished when UGT2B7 expression was selectively inhibited, implying potential interactions between the two isoforms. Minor changes to UGT1A4, UGT2B4 and UGT2B7 activity were also observed when UGT1A9 expression was selectively down regulated. To our knowledge, this represents the first piece of evidence that UGT protein-protein interactions occur in human hepatocytes and suggests that expression levels of UGT2B7 may directly impact the glucuronidation activity of selective UGT1A9 substrates. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 40 条
  • [21] The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers
    Kurkela, M
    Hirvonen, J
    Kostiainen, R
    Finel, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 68 (12) : 2443 - 2450
  • [22] Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs)
    Kurkela, M
    García-Horsman, JA
    Luukkanen, L
    Mörsky, S
    Taskinen, J
    Baumann, M
    Kostiainen, R
    Hirvonen, J
    Finel, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) : 3536 - 3544
  • [23] Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6
    Kurkela, Mika
    Patana, Anne-Sisko
    Mackenzie, Peter I.
    Court, Michael H.
    Tate, Christopher G.
    Hirvonen, Jouni
    Goldman, Adrian
    Finel, Moshe
    [J]. PHARMACOGENETICS AND GENOMICS, 2007, 17 (02) : 115 - 126
  • [24] Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling
    Lewis, Benjamin C.
    Mackenzie, Peter I.
    Miners, John O.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2011, 82 (12) : 2016 - 2023
  • [25] Disposition of flavonoids via enteric recycling: Determination of the UDP-Glucuronosyltransferase Isoforms responsible for the metabolism of flavonoids in intact caco-2 TC7 cells using siRNA
    Liu, Xing
    Tam, Vincent H.
    Hu, Ming
    [J]. MOLECULAR PHARMACEUTICS, 2007, 4 (06) : 873 - 882
  • [26] UDP-glucuronosyltransferase, the role of the amino terminus in dimerization
    Meech, R
    Mackenzie, PI
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) : 26913 - 26917
  • [27] In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promises
    Miners, JO
    Knights, KM
    Houston, JB
    Mackenzie, PI
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 71 (11) : 1531 - 1539
  • [28] Predicting human drug glucuronidation parameters: Application of in vitro and in silico modeling approaches
    Miners, JO
    Smith, PA
    Sorich, MJ
    McKinnon, RA
    Mackenzie, PI
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 : 1 - 25
  • [29] Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5phenylhydantoin by human UDP-Glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: Effects of UGT-UGT interactions
    Nakajima, Miki
    Yamanaka, Hiroyuki
    Fujiwara, Ryoichi
    Katoh, Miki
    Yokoi, Tsuyoshi
    [J]. DRUG METABOLISM AND DISPOSITION, 2007, 35 (09) : 1679 - 1686
  • [30] Oligomerization of the UDP-glucuronosyltransferase 1A proteins -: Homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation
    Operana, Theresa N.
    Tukey, Robert H.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (07) : 4821 - 4829